TOI The Oncology Institute, Inc.
USHealthcareAs of 2026-07-08 16:00
Why TOI matters now
The Oncology Institute, Inc. (TOI) is a US stock in Healthcare. The latest InvestLog snapshot shows $5.65 with -2.59% on the session and $564.9M in market capitalization; recent performance reads 1-month +28.29% and YTD +47.75%.
The latest financial table shown here is Q1 2026, with revenue of $147.4M, net income of $-2.5M, and EPS of $-0.02. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -4.9%.
The latest indexable market news headline is "Best Cheap Stocks Under $10 to Buy Now in July" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Buy with a median target of $7.50; recent insider activity includes Podnos Yale filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
-328.82
P/S
0.96
EV/EBITDA
-20.55
DCF Value
$-5.89
FCF Yield
-4.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
14.8%
Operating Margin
-6.0%
Net Margin
-8.0%
ROE
326.8%
ROA
-25.9%
ROIC
-33.8%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $147.4M | $-2.5M | $-0.02 |
| Q4 2025 | $142.0M | $-7.5M | $-0.04 |
| FY 2025 | $502.7M | $-60.6M | $-0.54 |
| Q3 2025 | $136.6M | $-16.5M | $-0.14 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$7.50
Target (Median)
$7.50
Target Range
$7.00 - $8.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Exchange
—
Beta
0.41
The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physician care, integrated on-site infusion and medication dispensing facilities, and advanced clinical trial management. The institute also provides radiation therapy, specialized outpatient programs for stem cell transplants and transfusions, and robust patient support services. Furthermore, TOI is actively involved in operating palliative care initiatives and overseeing clinical trials. These services are specifically designed to meet the needs of adult and senior cancer patients. The company maintains a significant operational footprint with 67 clinic locations. The Oncology Institute was established in 2007 and is headquartered in Cerritos, California.